🇨🇦 Canada Country × Condition
myotonic dystrophy 1 Clinical Trials in Canada
Active clinical trials for myotonic dystrophy 1 with research sites in Canada. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇨🇦 Canada
Active Trials in Canada (3)
NCT03981575
Recruiting
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Enrollment
700 pts
Country
🇨🇦 Canada
Virginia Commonwealth University
View Trial → NCT07220603 Phase 2
Recruiting
An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)
Enrollment
48 pts
Country
🇨🇦 Canada
PepGen Inc
View Trial → NCT06667453 Phase 2
Recruiting
A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
Enrollment
24 pts
Country
🇨🇦 Canada
PepGen Inc
View Trial → Frequently Asked Questions
How many myotonic dystrophy 1 clinical trials are active in Canada?
There are currently 3 active clinical trials for myotonic dystrophy 1 with sites in Canada, of which 3 are actively recruiting patients.
How can I join a myotonic dystrophy 1 clinical trial in Canada?
To join a myotonic dystrophy 1 clinical trial in Canada, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Canada directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are myotonic dystrophy 1 trials in Canada?
Active myotonic dystrophy 1 trials in Canada span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology